Some Cells in Your Body Are Older Than You. Which Ones?

 The Parts of You Older Than You Are

In the summer of 1963, when the Partial Test Ban Treaty finally halted most atmospheric nuclear testing, the air above the planet was carrying nearly twice its natural share of carbon-14. The isotope wasn't a byproduct of the bombs themselves so much as a side effect of their neutrons, which struck nitrogen atoms in the upper atmosphere and converted them into carbon-14 at a rate far beyond what cosmic rays alone had ever produced. That carbon moved through the air, into plants by way of photosynthesis, into the animals that ate the plants, and into the humans who ate both. It settled into new tissue, new DNA, new cells  a radioactive fingerprint left behind by the arms race, embedded in the biology of everyone alive, or born, in the decades that followed.

      

It took until the early 2000s for anyone to work out what that fingerprint was good for. Jonas Frisén's laboratory at the Karolinska Institute, working with Kirsty Spalding, showed that the ratio of carbon-14 to ordinary carbon-12 in a cell's genomic DNA stays fixed at whatever the atmospheric level happened to be on the day that DNA was last copied. A cell that never divides again after that point carries the timestamp forward, unchanged, for as long as it survives. Because atmospheric carbon-14 has fallen along a well-documented curve since 1963, measuring that ratio in a tissue sample lets researchers calculate, with real precision, when the cells inside it were made. It's retrospective birth dating, and it turned an old assumption about the body  that it renews itself in some tidy, wholesale fashion every several years  into something closer to folklore.

When Frisén's group and others began applying the method to different tissues, the ages that came back barely agreed with each other, even within the same person on the same day. Some cells were only weeks old. Others carried a timestamp from childhood, or from adolescence, or in a few remarkable cases, from before the person had been born at all.

The lining of the small intestine turns over in roughly four to five days, worn down by digestion and rebuilt from stem cells at the base of each crypt. Skin replaces its outer layer on a scale of weeks rather than days. These are the tissues most people picture when they hear that the body replaces itself, and they're real, but they turn out to be the exception rather than the rule.

Red blood cells last about 120 days before the spleen filters them out of circulation, a figure established long before carbon dating entered the picture. Neutrophils, the most abundant white blood cell, were taught for decades to survive less than a day in the bloodstream, an estimate that held until researchers used deuterium labeling instead of older, more indirect methods and found human neutrophils circulating for something closer to five and a half days. Even a fact as basic as how long an immune cell lives turned out to depend heavily on how it was measured. Memory T cells, by contrast, can persist for years, sometimes decades, quietly holding the outline of an infection fought off long ago.

The heart complicates the picture further. Olaf Bergmann, also working with Frisén, used carbon dating in 2009 to show that cardiomyocytes, the muscle cells that make the heart contract, do renew, but barely. Turnover runs at around 1 percent per year in a 25-year-old and falls further with age, so that less than half of a person's cardiomyocytes are ever exchanged across an ordinary lifetime. The organ has to keep beating, in tightly coordinated mechanical and electrical rhythm, the entire time it's being very slowly rebuilt around itself.

Microglia, the resident immune cells of the brain and spinal cord, take a different route again. They arrive early, migrating in from yolk-sac progenitors during embryonic development, and then maintain their own numbers through local self-renewal rather than being restocked from the bloodstream the way most immune cells are. A 2017 study by Pedro Réu, again from the Frisén lab, put the average age of human microglia at a little over four years, though individual cells varied considerably, some persisting well beyond that average.

None of this compares, though, to what happens inside the eye. The lens begins forming around the fourth week of embryonic development, when a patch of surface tissue folds inward to become the lens placode. The earliest fiber cells it produces compact together at the center and form what's called the embryonic nucleus, fully assembled before birth. As a person ages, the lens doesn't discard those original cells and rebuild. It keeps adding new fiber cells at the outer edge instead, layer over layer, the way growth rings accumulate around the core of a tree. The oldest fibers get pushed toward the middle and stay there, sealed off from turnover, because the lens has no blood supply and no mechanism for clearing out old material once it has been compacted in.

To become transparent, those fiber cells also strip themselves down: they lose their nucleus, their mitochondria, nearly every organelle capable of scattering light, in a controlled process not unlike the way red blood cells shed their own nucleus to make room for hemoglobin. What sits at the center of an adult lens, then, is a mass of oxygen-starved, organelle-free cellular material that has been there, chemically stable but never replaced, since before that person drew a first breath. Calling it the single oldest structure in the human body would overstate a case that's still being refined tissue by tissue, but it's hard to find anything else in the body that keeps a piece of its prenatal self this intact, for this long.

Frisén's 2005 paper, the one that introduced retrospective dating in the first place, made a related claim about the brain: neurons in the cerebral cortex are, on average, close in age to the person carrying them, meaning the adult cortex generates few if any new neurons to replace the ones lost over a lifetime. That finding lined up with an assumption running back through twentieth-century neuroscience, that the adult brain's neuronal population was essentially fixed.

The exceptions are where the science gets genuinely contested. Rodent brains sustain neurogenesis well into adulthood in at least two regions, the hippocampus and the olfactory bulb, and for years researchers assumed something similar held for humans. An influential 1998 study by Peter Eriksson, using a labeling compound originally given to cancer patients to track tumor growth, reported new neurons forming in the adult human hippocampus. That result shaped two decades of research and clinical speculation about depression, memory, and therapies built around encouraging that growth.

Then, in 2018, a study led by Shawn Sorrells and Arturo Alvarez-Buylla examined postmortem human hippocampal tissue and found neurogenesis markers dropping off sharply in childhood, effectively undetectable in adult samples. Months later, a separate team led by Maura Boldrini reported the opposite in Cell Stem Cell: evidence of neurogenesis persisting into old age, even if it slows with time. Both groups worked from human brain tissue. Both used trained pathologists and validated antibodies. They still reached opposite conclusions, and the disagreement hasn't been settled since, partly because postmortem interval, fixation method, and antibody specificity all shift the results in ways that are difficult to fully control for.

The olfactory bulb tells a related but distinct story. In rodents, it's one of the most active neurogenic regions in the whole brain, constantly restocked by neurons migrating in from elsewhere. When Bergmann's team applied carbon dating to human olfactory bulb tissue in 2012, they found neurons there were nearly as old as the people they came from, evidence that whatever neurogenesis happens in the human olfactory system contributes far less to the adult population than it does in mice. A neurogenic niche that matters enormously in one mammal barely registers in another, closely related one.

There's one more case worth sitting with, and it belongs to reproduction rather than sensory biology. Oocytes begin their existence before birth too. A fetal ovary generates its entire lifetime supply of oogonia, and by the time of birth, those cells have already entered meiosis and stalled in an arrested state, prophase I, where they can remain for years or decades until one is finally selected for ovulation. A woman ovulating at forty is releasing an egg cell whose meiotic pause began before she herself was born, arguably the clearest case in the whole body of a cell whose formation predates the person carrying it.

None of this happens because long-lived cells are somehow built better than short-lived ones. It happens because replacing certain cells is either mechanically difficult or actively risky. A neuron carrying thousands of synaptic connections isn't an interchangeable part; swapping it out means losing whatever specific function it encoded, or asking a replacement to rebuild an equivalent web of connections from nothing. A lens fiber cell has to stay optically transparent and precisely positioned relative to millions of others, which rules out the kind of constant churn seen in skin or gut lining. A cardiomyocyte has to stay embedded in a synchronized electrical network that can't tolerate gaps. In each case, longevity looks less like a reward than a structural requirement.

It comes at a price. Cells that never divide also never get the chance to dilute or discard the damage that builds up inside them: oxidized proteins, mutated mitochondrial DNA, misfolded aggregates that a dividing cell might simply outcompete or shed through turnover. Long-lived neurons and cardiomyocytes rely instead on internal maintenance systems, protein quality control, autophagy, antioxidant defenses, to manage decades of wear without ever getting a clean replacement. Whether that maintenance debt is a major driver of how the brain and heart age, or just one factor among several, remains one of the more open questions connecting cell biology to aging research generally.

What's left unsettled is not just a matter of curiosity. If human adults do generate new hippocampal neurons, even at a modest rate, that changes how researchers think about treating depression, memory loss, and neurodegeneration through pathways meant to encourage neurogenesis. If they don't, those same strategies rest on a foundation that may not exist in the tissue they're meant to help. Sorrells's group and Boldrini's group have not resolved their disagreement, and short of a technique that can reliably date and count new neurons in living human brain tissue rather than postmortem samples, it isn't obvious how the standoff gets settled at all.

YOU MAY ALSO LIKE

Why Did People Dream in Black and White? The Science of Dreaming

Why Can't You Remember Being a Baby? The Science of Infantile Amnesia